NRX Pharmaceuticals (NRXP) Share-based Compensation (2020 - 2026)

NRX Pharmaceuticals (NRXP) has 7 years of Share-based Compensation data on file, last reported at $600000.0 in Q1 2026.

• On a quarterly basis, Share-based Compensation changed N/A year-over-year to $600000.0 in Q1 2026; TTM through Mar 2026 was $600000.0, a 153.16% increase from a year earlier, with the FY2025 full-year figure at $500000.0, up 2.88% from the prior year.
• Share-based Compensation for Q1 2026 stood at $600000.0, up from -$420000.0 in the prior quarter.
• Over the last five years, Share-based Compensation for NRXP reached as high as $3.6 million in Q4 2022 and fell as low as -$1.6 million in Q4 2023.
• Historically, Share-based Compensation has averaged $454187.5 across 5 years, with a median of $296500.0 in 2023.
• Across the five-year window, Share-based Compensation surged 258.6% in 2022 and plunged 1076.74% in 2025, its largest moves.
• Year by year, Share-based Compensation stood at $3.6 million in 2022, then slumped by 144.03% to -$1.6 million in 2023, then jumped by 102.7% to $43000.0 in 2024, then plunged by 1076.74% to -$420000.0 in 2025, then soared by 242.86% to $600000.0 in 2026.
• Per Business Quant data, the three most recent Share-based Compensation figures were $600000.0 in Q1 2026, -$420000.0 in Q4 2025, and $68000.0 in Q3 2025.